CAS 4803-27-4|Anthramycin

Introduction:Basic information about CAS 4803-27-4|Anthramycin, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameAnthramycin
CAS Number4803-27-4Molecular Weight315.32400
Density1.505 g/cm3Boiling Point679.872ºC at 760mmHg
Molecular FormulaC16H17N3O4Melting Point188-194ºC
MSDS/Flash Point364.974ºC

Names

NameAnthramycin
SynonymMore Synonyms

Anthramycin BiologicalActivity

DescriptionAnthramycin, a member of the pyrolobenzodiazepine (PBD) family, is a potent antibiotic. Anthramycin has potent antitumor activity. Anthramycin can act as an potent antagonist of cholecystokinin in the central nervous system in mice[1][2][3].
Related CatalogResearch Areas >>CancerSignaling Pathways >>GPCR/G Protein >>Cholecystokinin Receptor
In VitroANT is delivered through the skin for PG (propylene glycol), TC (Transcutol P) and PGML (propylene glycol monolaurate) with the active “tracking” the skin penetration of both PG and TC[1]. Anthramycin (10-1000 μM) dose not affect the ATPase activity of heart mitochondria[3].
In VivoAnthramycin (0-0.5 mg/kg, IP, once) has potent anti-CCK (cholecystokinin) activity and antinociceptive effects in the central nervous system in mice[2]. Anthramycin (0.1-0.5 mg/kg, SC, daily for 8 days) has no effect on mitochondrial metabolism of the rat heart[3]. Animal Model: Male ddY mice (20 ± 2 g, 12-14 each group)[2] Dosage: 0, 0.3, and 0.5 mg/kg Administration: IP, once, 10 min before the intracisternal (i.c.) injection of CCK Result: Significantly inhibited CCK-induced increase in the pain threshold in a dose-dependent manner. Almost completely suppressed the antinociceptive effects of CCK at the higher dose (0.5 mg/kg). Animal Model: Female CFN Gif rats (140-180 g)[3] Dosage: 0.1 mg/kg, 0.25 mg/kg, and 0.5 mg/kg Administration: SC, daily for 8 days Result: Recorded no differences between anthramycin- and DMSO-treated rats with respect to P/O ratios, respiration rates, and ATPase activity of heart mitochondria.
References

[1]. Haque T, et al. Topical delivery of anthramycin II. Influence of binary and ternary solvent systems. Eur J Pharm Sci. 2018 Aug 30;121:59-64.

[2]. Kubota K, et al. Cholecystokinin antagonism by anthramycin, a benzodiazepine antibiotic, in the central nervous system in mice. Brain Res. 1989 Apr 17;485(1):62-6.

[3]. Cargill C, et al. Effects of daunomycin and anthramycin on electrocardiogram and mitochondrial metabolism of the rat heart. J Natl Cancer Inst. 1974 Aug;53(2):481-6.

Chemical & Physical Properties

Density1.505 g/cm3
Boiling Point679.872ºC at 760mmHg
Melting Point188-194ºC
Molecular FormulaC16H17N3O4
Molecular Weight315.32400
Flash Point364.974ºC
Exact Mass315.12200
PSA115.89000
LogP1.36060
Index of Refraction1.723
InChIKeyVGQOVCHZGQWAOI-YQRHFANHSA-N
SMILESCc1ccc2c(c1O)NC(O)C1CC(C=CC(N)=O)=CN1C2=O

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UY8429000
CHEMICAL NAME :
1H-Pyrrolo(2,1-c)(1,4)benzodiazepine-2-acrylamide, 5,10,11,11a-tetrahydro-9,11-dihydroxy-8- methyl-5-oxo-, (E)-
CAS REGISTRY NUMBER :
4803-27-4
LAST UPDATED :
199712
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C16-H17-N3-O4
MOLECULAR WEIGHT :
315.36
WISWESSER LINE NOTATION :
T C576 BVN IM DUTT&J E1U1VZ HQ KQ L1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
650 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
Unscheduled DNA synthesis
TEST SYSTEM :
Human Fibroblast
DOSE/DURATION :
200 nmol/L
REFERENCE :
JBCHA3 Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905- Volume(issue)/page/year: 254,605,1979

Synonyms

(11R,11aS)-5,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1H-pyrrolo<2,1-c><1,4>benzodiazepin-2-trans-acrylamid
3-(9,11-dihydroxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-2-yl)-acrylamide
Antramycin
CAS 881445-79-0|4-(5-((2-(Cyclohexylamino)-2-oxoethyl)thio)-1,3,4-oxadiazol-2-yl)benzoic acid
CAS 881445-86-9|3-(4-bromophenyl)-4-(prop-2-en-1-yl)-5-(prop-2-yn-1-ylsulfanyl)-4H-1,2,4-triazole
Recommended......
TOP